Muhammed Yayla

Dr. Muhammed Yayla

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
MEMucahit Emet
Mucahit Emet
HOHalil Ozcan
Halil Ozcan
LOLutfu Ozel
Lutfu Ozel
MYMuhammed Yayla
Muhammed Yayla
ZHZekai Halici
Zekai Halici
AHAhmet Hacimuftuoglu
Ahmet Hacimuftuoglu
After a Turkish scientist took Nobel Prize due to his contributions to understand clock genes, melatonin, closely related to these genes, may begin to shine. Melatonin, a hormone secreted from the pineal gland at night, plays roles in regulating sleep-wake cycle, pubertal development and seasonal adaptation. Melatonin has antinociceptive, antidepressant, anxiolytic, antineophobic, locomotor activity-regulating, neuroprotective, anti-inflammatory, pain-modulating, blood pressure-reducing, retinal, vascular, anti-tumor and antioxidant effects. It is related with memory, ovarian physiology, and osteoblast differentiation. Pathologies associated with an increase or decrease in melatonin levels are summarized in the review. Melatonin affects by four mechanisms: 1) Binding to melatonin receptors in plasma membrane, 2) Binding to intracellular proteins such as calmoduline, 3) Binding to Orphan nuclear receptors, and 4) Antioxidant effect. Receptors associated with melatonin are as follows: 1) Melatonin receptor type 1a: MT1 (on cell membrane), 2) Melatonin receptor type 1b: MT2 (on cell membrane), 3) Melatonin receptor type 1c (found in fish, amphibians and birds), 4) Quinone reductase 2 enzyme (MT3 receptor, a detoxification enzyme), 5) RZR/RORα: Retinoid-related Orphan nuclear hormone receptor (with this receptor, melatonin binds to the transcription factors in nucleus), and 6) GPR50: X-linked Melatonin-related Orphan receptor (it is effective in binding of melatonin to MT1). Melatonin agonists such as ramelteon, agomelatine, circadin, TIK-301 and tasimelteon are introduced and side effects will be discussed. In conclusion, melatonin and related drugs is a new and promising era for medicine. Melatonin receptors and melatonin drugs will take attention with greater interest day by day in the future.

1 March 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MYMuhammed Yayla
Muhammed Yayla
ZHZekai Halici
Zekai Halici
BUBunyami Unal
Bunyami Unal
YBYasin Bayir
Yasin Bayir
EAErol Akpinar
Erol Akpinar
FGFatma Gocer
Fatma Gocer

17 December 2013 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
OAOmer Araz
Omer Araz
EDElif Demirci
Elif Demirci
EUElif Yilmazel Ucar
Elif Yilmazel Ucar
MCMuhammet Calik
Muhammet Calik
DPDidem Pulur
Didem Pulur
MAMetin Akgün
Metin Akgün
Different medical therapies are employed in acute lung injury (ALI) but there is still a debate about the efficacy of these drugs. Among these therapies steroids are clinically applied and bosentan is experimentally studied. The aim of this study was to evaluate the efficacy of these two drugs to treat inflammation in ALI by histopathological comparison.

1 March 2019 in Neurotoxicology and Teratology
Verified
Journal Article
Closed access
TYTugba Nurcan Yuksel
Tugba Nurcan Yuksel
MYMuhammed Yayla
Muhammed Yayla
ZHzekai halici
zekai halici
ECElif Cadirci
Elif Cadirci
BPBeyzagul Polat
Beyzagul Polat
DKDuygu Kose
Duygu Kose

1 August 2016 in Peptides
Verified
Journal Article
Closed access
ECElif Cadirci
Elif Cadirci
ZHzekai halici
zekai halici
MYMuhammed Yayla
Muhammed Yayla
ETErdem Toktay
Erdem Toktay
YBYasin Bayir
Yasin Bayir
AAAbdulmecit Albayrak
Abdulmecit Albayrak

1 September 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
ZKZulkuf Kaya
Zulkuf Kaya
MYMuhammed Yayla
Muhammed Yayla
ICIrfan Cinar
Irfan Cinar
NANihal Efe Atila
Nihal Efe Atila
SOSevilay Ozmen
Sevilay Ozmen
DBDilek Bilici
Dilek Bilici